The abstract is read at the publisher; the summary is JClub's.
In outbred CD1 mice, CGRP-induced light aversion is only fully rescued by combined blockade of CT-based receptors (AC187) and the canonical CGRP receptor (olcegepant), not by either alone.
- Why it matters: Migraine therapies targeting only the canonical CGRP receptor may miss contributions from CT-based receptors, leaving photophobia and gastrointestinal side effects incompletely explained.
- What they did: CD1 mice were tested for light aversion and diarrhoea after CGRP or amylin agonists, using olcegepant and AC187; diarrhoea was also assessed after CGRP in C57BL/6J mice.
- The result: CGRP and amylin both induced light aversion in CD1 mice and diarrhoea in both strains; olcegepant fully blocked CGRP-induced diarrhoea, while AC187 only partially blocked it at high doses.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.